The U.S. anesthesia drugs market is expected to be worth more than $3 billion by 2018, according to a MarketReportsOnline report.
Here are three findings from the report:
• The general intravenous anesthesia drugs market is dominating the U.S. anesthesia drugs market.
• Propofol and Benzodiazepines Class (Diazepam and Midazolam) are the top contributors to intravenous anesthetic drugs.
• Baxter International, Endo Health Solutions, AstraZeneca and Abbott Laboratories are four main players, but other companies also play a major role in the market.
More articles on anesthesia:
NAPA Dr. Joseph Marino to study treatment for postoperative pain relief
ASA President Dr. J.P. Abenstein on the physician-led ASC anesthesia team
Dr. Eugene Pereira joins Sarasota Memorial Health Care System